The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade ...

Circulating tumor DNA (ctDNA) in cerebrospinal fluid (CSF) of patients with glioma had a high concordance with tumor DNA and ...

Calidi Biotherapeutics (NYSE American: CLDI) , a clinical-stage biotechnology company developing targeted immunotherapies, reported a reduced net los ...

NeOnc Technologies (NTHI) announced that the U.S. Food and Drug Administration, FDA, has granted Rare Pediatric Disease Designation, RPDD, to ...

NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) shares slid as the Westlake Village, Calif.-based company a clinical-stage medical biotechnology concerm, announced that the U.S. Food and Drug ...

NeOnc Technologies Holdings, Inc. (NASDAQ Global Market: NTHI), a clinical-stage medical biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare ...

BOCA RATON, Fla., March 31, 2025 (GLOBE NEWSWIRE) -- Xeriant, Inc. (OTCQB: XERI) ("Xeriant" or "the Company"), dedicated to the discovery, development, and commercialization of disruptive technologies ...